Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
申请人:——
公开号:US20030225091A1
公开(公告)日:2003-12-04
Compounds that are dual aP2/k-FABP inhibitors are provided having the formula
1
wherein A, B, X, Y, R
1
, R
2
and R
3
are as described herein.
A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing dual aP2/k-FABP inhibitors alone or in combination with at least one other antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.